INLB
Item 9 Labs Corp.Company Information
- Company Name
- Item 9 Labs Corp.
- CIK
- CIK0001500123
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- INLB: OTC
- Fiscal Year End
- September 30
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3843
- SIC Description
- Dental Equipment & Supplies
- Ticker
- INLB
SEC filing data through
Insider Sentiment
- Last purchase
- 2014-08-21
- Last sale
- —
- Shares purchased (TTM)
- 47,500
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2023-08-21
- Price on filing date
- —
- 1-month reaction
- -23.53%
- 3-month reaction
- -82.06%
Balance Sheet
Values in millions ($)| Line item | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||||
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 4 | 2 | 0 | 1 | ||||||
| Accounts Receivable Net Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 1 | 0 | 1 | ||||||
| Deferred Costs Current | - | - | - | - | - | - | - | - | 8 | 6 | 3 | 2 | 3 | ||||||
Assets Current | |||||||||||||||||||
| Assets Current | 3 | 4 | 3 | 4 | 6 | 7 | 8 | 10 | 11 | 14 | 7 | 3 | 4 | ||||||
| Inventory Net | 2 | 3 | 2 | 2 | 4 | 5 | 5 | 6 | - | - | - | 2 | - | ||||||
| Prepaid Expense And Other Assets | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 25 | 25 | 23 | 21 | 26 | 24 | 19 | 11 | 9 | 8 | 8 | 7 | 7 | ||||||
| Operating Lease Right Of Use Asset | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Equity Method Investments | - | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Deposits Assets Current | - | - | - | - | - | - | - | - | 1 | 1 | 2 | 1 | 1 | ||||||
| Receivables Net Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets | - | - | - | - | 1 | 1 | - | - | - | - | - | - | - | ||||||
| Accounts And Notes Receivable Net | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Sales Commission | - | - | - | - | - | - | 0 | 0 | - | - | - | - | - | ||||||
| Escrow Deposit | 5 | 5 | 8 | 8 | 9 | 10 | 13 | 18 | - | - | - | - | - | ||||||
| Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | - | 1 | - | - | - | 1 | - | ||||||
| Other Assets Noncurrent | 3 | 4 | 4 | 1 | - | - | - | 1 | - | - | - | - | - | ||||||
| Assets Held For Sale Not Part Of Disposal Group | 7 | 7 | 7 | 7 | - | - | - | - | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 11 | 11 | 11 | 12 | 19 | 20 | 18 | 19 | 127 | 129 | 8 | 8 | 8 | ||||||
| Goodwill | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 112 | 114 | 115 | 111 | 121 | 121 | 117 | 117 | 150 | 153 | 26 | 21 | 22 | ||||||
Liabilities And Stockholders Equity | |||||||||||||||||||
| Accounts Payable Current | 7 | 7 | 6 | 6 | 6 | 6 | 4 | 4 | 4 | 4 | 3 | 2 | 2 | ||||||
| Employee Related Liabilities Current | 2 | 1 | 1 | 2 | 2 | 3 | 2 | 3 | 0 | 1 | 0 | 2 | 0 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Interest Payable Current | 8 | 6 | 4 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | 2 | 2 | 4 | 3 | 2 | 1 | 2 | 1 | 3 | 3 | 2 | 0 | 1 | ||||||
| Deferred Revenue Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - | - | - | - | ||||||
| Notes Payable Current | 30 | 22 | 21 | 16 | 25 | 21 | 4 | 5 | 1 | 2 | 2 | 3 | - | ||||||
Liabilities Current | |||||||||||||||||||
| Liabilities Current | 59 | 47 | 47 | 41 | 39 | 36 | 16 | 15 | 11 | 12 | 10 | 10 | 8 | ||||||
| Accrued Income Taxes Current | - | - | - | - | 0 | 0 | - | - | - | - | - | - | 0 | ||||||
| Short Term Non Bank Loans And Notes Payable | - | - | - | - | - | - | - | - | - | - | - | - | 3 | ||||||
| Taxes Payable Current | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Notes Payable Current | 4 | 3 | 4 | 4 | 3 | 3 | 2 | 1 | 1 | 1 | 2 | 2 | 0 | ||||||
| Deferred Tax Liabilities Interests In Financial Assets Continued To Be Held | 6 | 6 | 6 | 6 | - | - | 6 | - | - | - | - | - | - | ||||||
| Deferred Revenue Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Long Term Notes Payable | - | 1 | 0 | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Notes Payable | - | - | - | - | - | - | - | - | 3 | 3 | 2 | 2 | - | ||||||
| Long Term Debt Noncurrent | - | 7 | 7 | 7 | 1 | 2 | 16 | 15 | - | - | - | 2 | 3 | ||||||
| Liabilities | 59 | 56 | 54 | 49 | 42 | 38 | 33 | 31 | 14 | 15 | 13 | 13 | 11 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | |||||||||||||||||||
| Stockholders Equity | 53 | 58 | 60 | 62 | 78 | 83 | 84 | 86 | 136 | 138 | 13 | 8 | 11 | ||||||
| Additional Paid In Capital | 144 | 143 | 142 | 140 | 138 | 137 | 135 | 133 | 174 | 176 | 51 | 44 | 30 | ||||||
| Retained Earnings Accumulated Deficit | -78 | -72 | -68 | -65 | -47 | -41 | -37 | -34 | -25 | -24 | -24 | -23 | -16 | ||||||
| Stockholders Equity Before Treasury Stock | - | - | - | - | - | - | - | - | 149 | 152 | - | - | - | ||||||
| Treasury Stock Value | -13 | -13 | -13 | -13 | -13 | -13 | -13 | -13 | -13 | -13 | -13 | -13 | -3 | ||||||
| Minority Interest | -0 | -0 | -0 | -0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Liabilities And Stockholders Equity | 112 | 114 | 115 | 111 | 121 | 121 | 117 | 117 | 150 | 153 | 26 | 21 | 22 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | ||||||
| Debt Instrument Unamortized Discount Current | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | ||||||
| Common Stock Shares Issued | 115 | 114 | 112 | 110 | 109 | 110 | 110 | 107 | 105 | 104 | 75 | 68 | 64 | ||||||
| Shares Outstanding | 102 | 102 | 100 | 98 | 96 | 98 | 98 | 95 | 92 | 92 | 68 | 56 | 61 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialItem 9 Labs Corp. (INLB) — SEC Financial Statements & Analysis
Item 9 Labs Corp. (INLB) is a dental equipment & supplies company, incorporated in DE. Item 9 Labs Corp. trades on OTC as: INLB. Item 9 Labs Corp. (INLB)'s most recent SEC filing is a Form 10-Q for the period ended 2023-06-30, filed with the SEC on 2023-08-21. Based on that filing, Item 9 Labs Corp. carries a market cap of $5.45M, a P/E ratio of -0.18x, a P/B ratio of 0.10x, a P/S ratio of 0.28x, an enterprise value of $39.17M, and an EV/EBITDA multiple of -2.09x. On profitability, it posts a gross margin of 49.79%, an operating margin of -102.37%, a net margin of -157.71%, a Return on Equity (ROE) of -47.36%, a Return on Assets (ROA) of -26.71%, and a Return on Invested Capital (ROIC) of -20.75%. Per share, it reports EPS of $-0.30, diluted EPS of $-0.30, free cash flow per share of $-0.03, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -17.44% year-over-year, net income growth of 42.83% year-over-year, and EPS growth of 34.87% year-over-year. On the balance sheet, it maintains a current ratio of 0.06x, a quick ratio of 0.02x, working capital of $-55.47M, a debt-to-equity ratio of 1.13x, a debt ratio of 0.53, an interest coverage ratio of -2.19x, free cash flow of $-2.60M (TTM), and net debt of $33.72M. Figures sourced from SEC EDGAR.
- Market Cap
- $5.45M
- P/E TTM
- -0.18x
- EPS TTM
- $-0.30
- P/B TTM
- 0.10x
- ROE TTM
- -47.36%
- ROA TTM
- -26.71%
- Debt To Equity
- 1.13x
- Free Cash Flow TTM
- $-2.60M
- Net Revenue TTM Growth 1Y
- -17.44%
Data as of 2023-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Item 9 Labs Corp. in?
Item 9 Labs Corp. (INLB) operates in the Dental Equipment & Supplies industry.
What exchange does INLB trade on?
Item 9 Labs Corp. (INLB) trades on the OTC.
Where is Item 9 Labs Corp. incorporated?
Item 9 Labs Corp. is incorporated in DE.
When was Item 9 Labs Corp. (INLB)'s most recent SEC filing?
Item 9 Labs Corp. (INLB)'s most recent SEC filing is a Form 10-Q for the period ended 2023-06-30, filed with the SEC on 2023-08-21.
What is INLB's market cap?
Item 9 Labs Corp. (INLB) has a market capitalization of $5.45M as of 2023-06-30.
What is INLB's EPS (earnings per share)?
Item 9 Labs Corp. (INLB)'s trailing twelve month EPS is $-0.30 as of 2023-06-30.
What is INLB's ROE (return on equity)?
Item 9 Labs Corp. (INLB)'s trailing twelve month Return on Equity (ROE) is -47.36% as of 2023-06-30.
What is INLB's ROA (return on assets)?
Item 9 Labs Corp. (INLB)'s trailing twelve month Return on Assets (ROA) is -26.71% as of 2023-06-30.
What is INLB's ROIC (return on invested capital)?
Item 9 Labs Corp. (INLB)'s trailing twelve month Return on Invested Capital (ROIC) is -20.75% as of 2023-06-30.
What is INLB's EV/EBITDA?
Item 9 Labs Corp. (INLB)'s trailing twelve month EV/EBITDA is -2.09x as of 2023-06-30.